Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia

• Status: Completed
• Trial end date: 2015-09-01
• Target enrollment: 0
• Participant gender: All

Summary

In a prospective randomized clinical trial involving adult patients undergoing elective surgery under general anesthesia, the investigators will enroll 216 patients, and evaluate 3 doses of prophylactic dexmedetomidine as a means to reduce postoperative shivering and quality of emergence from anesthesia versus placebo.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: American University of Beirut Medical Center
• Treatments: Anesthetics; Dexmedetomidine

Criteria

Inclusion Criteria:

• 18-80 year-old

• ASA class I, II, and III

• patients undergoing elective surgery under general anesthesia with an estimated time of 1-3 h

Exclusion Criteria:

• duration of surgery less than 1h or more than 3 h

• allergy to dexmedetomidine

• vasoactive antidepressant or analgesics

• obesity (BMI>30)

• fever

• pregnancy